These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

148 related articles for article (PubMed ID: 3281267)

  • 1. Antimetastatic agents. I. Role of cellular procoagulants in the pathogenesis of fibrin deposition in cancer and the use of anticoagulants and/or antiplatelet drugs in cancer treatment.
    Rickles FR; Hancock WW; Edwards RL; Zacharski LR
    Semin Thromb Hemost; 1988 Jan; 14(1):88-94. PubMed ID: 3281267
    [No Abstract]   [Full Text] [Related]  

  • 2. Assessment of anti-metastatic effects of anticoagulant and antiplatelet agents using animal models of experimental lung metastasis.
    Amirkhosravi A; Mousa SA; Amaya M; Meyer T; Davila M; Robson T; Francis JL
    Methods Mol Biol; 2010; 663():241-59. PubMed ID: 20617422
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Cancer, hemostasis and coaguloactive drugs].
    Nadiradze ISh
    Vopr Onkol; 1989; 35(12):1411-8. PubMed ID: 2692281
    [No Abstract]   [Full Text] [Related]  

  • 4. Antimetastatic agents. II. Summary of the interactions of tumor cells with blood coagulation factors, platelets, fibrinolytic factors, and inflammatory cells and their soluble mediators: potential for therapeutic interventions.
    Rickles FR; Hancock WW
    Semin Thromb Hemost; 1988 Jan; 14(1):126-32. PubMed ID: 3353730
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Coagulation, fibrinolysis, and fibrin deposition in acute lung injury.
    Idell S
    Crit Care Med; 2003 Apr; 31(4 Suppl):S213-20. PubMed ID: 12682443
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Inhibition of platelet function: does it offer a chance of better cancer progression control?
    Sierko E; Wojtukiewicz MZ
    Semin Thromb Hemost; 2007 Oct; 33(7):712-21. PubMed ID: 18000800
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Hemostasis and malignancy.
    Francis JL; Biggerstaff J; Amirkhosravi A
    Semin Thromb Hemost; 1998; 24(2):93-109. PubMed ID: 9579631
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [New anticoagulants].
    Levi M; Peters RJ; Piek JJ; Büller HR
    Ned Tijdschr Geneeskd; 2003 May; 147(19):909-15. PubMed ID: 12768805
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Oral anticoagulants and platelet anti-aggregants in the prevention of metastases: state of the art and perspectives of a combined therapy].
    Finzi G; Dettori AG
    Recenti Prog Med; 1989 Jan; 80(1):28-32. PubMed ID: 2652221
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Therapeutic role of coagulation in small cell lung cancers].
    LeBeau B
    Rev Mal Respir; 1996; 13(1):21-6. PubMed ID: 8650412
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Experimental thrombosis on a collagen coated arterioarterial shunt in rats: a pharmacological model to study antithrombotic agents inhibiting thrombin formation and platelet deposition.
    Freund M; Mantz F; Nicolini P; Gachet C; Mulvihill J; Meyer L; Beretz A; Cazenave JP
    Thromb Haemost; 1993 May; 69(5):515-21. PubMed ID: 8322274
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Haemostasis and cancer.
    Francis JL
    Med Lab Sci; 1989 Oct; 46(4):331-46. PubMed ID: 2693872
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Anticoagulants and antiplatelet drugs.
    Gallus AS
    Med J Aust; 1994 Jan; 160(2):78-82. PubMed ID: 8309373
    [No Abstract]   [Full Text] [Related]  

  • 14. Antiplatelet and anticoagulants drugs.
    Treat Guidel Med Lett; 2008 May; 6(69):29-36; quiz 2 p following 36. PubMed ID: 18443541
    [No Abstract]   [Full Text] [Related]  

  • 15. Changing trends in anti-coagulant therapies. Are heparins and oral anti-coagulants challenged?
    Fareed J; Iqbal O; Cunanan J; Demir M; Wahi R; Clarke M; Adiguzel C; Bick R
    Int Angiol; 2008 Jun; 27(3):176-92. PubMed ID: 18506123
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Rapid dissociation of platelet-rich fibrin clots in vitro by a combination of plasminogen activators and antiplatelet agents.
    Lam SC; Dieter JP; Strebel LC; Taylor TM; Muscolino G; Feinberg H; Le Breton GC
    J Pharmacol Exp Ther; 1991 Dec; 259(3):1371-8. PubMed ID: 1762085
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The rationale of anticoagulants in the treatment of cancer.
    Cliffton EE; Grossi CE
    J Med; 1974; 5(1):107-13. PubMed ID: 4275504
    [No Abstract]   [Full Text] [Related]  

  • 18. Activated coagulation factors in human malignant effusions and their contribution to cancer cell metastasis and therapy.
    Gieseler F; Lühr I; Kunze T; Mundhenke C; Maass N; Erhart T; Denker M; Beckmann D; Tiemann M; Schulte C; Dohrmann P; Cavaillé F; Godeau F; Gespach C
    Thromb Haemost; 2007 Jun; 97(6):1023-30. PubMed ID: 17549306
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Antithrombotic therapy in acute coronary syndrome].
    Chazov EI; Panchenko EP
    Ter Arkh; 2000; 72(3):65-75. PubMed ID: 10776658
    [No Abstract]   [Full Text] [Related]  

  • 20. [Prophylaxis and treatment of DIC syndrome in surgery of gastrointestinal neoplasms].
    Alipov VV; Kirichuk VF; Prigorodov MV
    Khirurgiia (Mosk); 2000; (3):61-4. PubMed ID: 10761388
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 8.